Carl Byrnes

Stock Analyst at Northland Capital Markets

(0.38)
# 2756
Out of 5,441 analysts
32
Total ratings
Success rate
Average return
19 Stocks
Name Action PT Current % Upside Ratings Updated
BWAY BrainsWay
Maintains: Outperform
15 19
12.06 57.55% 4 Aug 14, 2025
BLFS BioLife Solns
Maintains: Outperform
28 31
22.43 38.21% 2 Jan 8, 2025
TLSI TriSalus Life Scienc...
Initiates Coverage On: Outperform
13
3.53 254.11% 1 Oct 25, 2024
ONCT Oncternal Therapeuti...
Downgrades: Market Perform
2
0.53 277.36% 1 Sep 12, 2024
MDAI Spectral AI
Initiates Coverage On: Outperform
6
2.35 155.32% 1 Aug 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Dec 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
40 25
14.88 68.01% 1 Jul 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
240
3.57 6622.69% 1 May 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
2 1
n/a n/a 1 Dec 28, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
2 18
1.42 1167.61% 2 Sep 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
60 80
14.98 434.05% 4 Aug 17, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Nov 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
9
8.22 3.41% 1 Nov 17, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
9
n/a n/a 1 Oct 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
23
7.05 226.24% 3 Jul 26, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
30 24
1.85 1197.3% 4 May 5, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
128
n/a n/a 1 Apr 8, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
2000
2.24 89185.71% 1 Oct 22, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Sep 27, 2017